BSE filing, BSE: 543905. Summary written from the filing by ALFA Finder's alert engine.
Innokaiz India Ltd: key numbers
- Share price
- ₹12.59
- Market cap
- ₹12.87 Cr
- Revenue (annual)
- ₹9.50 Cr
- Net profit (annual)
- ₹-4.07 Cr
- P/E (TTM)
- -3.2×Sector 27.9×
- Promoter holding
- 71.99%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Innokaiz India Ltd
All →Innokaiz India Board Meeting Date
Innokaiz India Limited postponed its May 30 board meeting due to technical and administrative reasons. A revised date for financial result approval will be announced separately.
Innokaiz India Board Meeting Date
Innokaiz India scheduled a board meeting on May 30, 2026, to approve audited financial results. The trading window remains closed for designated employees until results declaration.
Innokaiz India Debt & Borrowing: ₹16.02 Cr
Innokaiz India Ltd (543905) confirmed it does not qualify as a 'Large Corporate' for the financial year ended March 31, 2026. Consequently, SEBI's mandatory debt-raising framework for large entities does not apply. The company reported outstanding borrowings of ₹16.02 Crore as of the period end.
- Value
- ₹16.02 Cr
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.